Fmoc-D-His(Boc)-OH

Catalog No. :
ACDTLA898
CAS No. :
210755-31-0
Molecular Formula :
C32H40N4O6
Molecular Weight :
576.69

IUPAC Name:cyclohexanamine Na-(((9H-fluoren-9-yl)methoxy)carbonyl)-Nt-(tert-butoxycarbonyl)-D-histidinate

Fmoc-D-His(Boc)-OH structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$115.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameFmoc-D-His(Boc)-OH
IUPAC Namecyclohexanamine Na-(((9H-fluoren-9-yl)methoxy)carbonyl)-Nt-(tert-butoxycarbonyl)-D-histidinate
MDL No.MFCD00270617
Molecular FormulaC32H40N4O6
Molecular Weight576.69
SMILESNC1CCCCC1.O=C(O)[C@H](NC(OCC2C3=C(C4=C2C=CC=C4)C=CC=C3)=O)CC5=CN(C(OC(C)(C)C)=O)C=N5
InChI KeyUDEXYAHZNOKVIG-VZYDHVRKSA-N
SynonymFMOC-D-HIS(BOC)-OH CHA;FMOC-N-IM-BOC-D-HISTIDINE CYCLOHEXYLAMMONIUM SALT;N-ALPHA-FMOC-N-IM-T-BOC-D-HISTIDINE CYCLOHEXYLAMMONIUM SALT;(2R)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]imidazol-4-yl]propanoic acid cyclohexanamine salt;Nα-Fmoc-Nim-Boc-D-histidine cyclohexylammonium salt99%;(9H-Fluoren-9-yl)MethOxy]Carbonyl D-His(Boc)-OH·CHA;Nα-Fmoc-Nim-Boc-D-histidine cyclohexylammonium salt;D-Histidine, 1-[(1,1-dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, compd. with cyclohexanamine (1:1)
CAS No.210755-31-0

Synthetic Route by SureRoute

1. ACDTLA898 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKVBC751 route compound structure diagram
    ACKVBC751157355-79-8 In Stock
  4. Then
  5. ACDTLA898 route product structure diagram
    ACDTLA898210755-31-0
Inquiry

2. ACDTLA898 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDTLA898 route product structure diagram
    ACDTLA898210755-31-0
Inquiry

Comments (0)